Luken Investment Analytics’s ResMed RMD Stock Holding History

Luken Investment Analytics’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1	Closed	-$241	–	353
2025 Q4	$241	Buy	+1	New	+$256	﹤0.01%	374

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Luken Investment Analytics's RMD Position: Q1 2026 in Review

Luken Investment Analytics sold out of ResMed (RMD) in Q1 2026, closing a stake of 1 share — an estimated $241 sold.

Luken Investment Analytics first reported a position in RMD in Q4 2025 and held it in 1 quarter. The position peaked at $241 in Q4 2025. 941 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Luken Investment Analytics reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
Luken Investment Analytics sold 1 ResMed share in Q1 2026, an estimated $241.
Luken Investment Analytics first reported a position in ResMed in Q4 2025 and held it in 1 quarter.
Luken Investment Analytics's ResMed position peaked at $241 in Q4 2025.
941 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Luken Investment Analytics's 13F filing for Q1 2026, filed 12 May 2026.